.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The landscape of advanced wearable health technology in India is shifting rapidly. Tata Group’s electronics retailer, Croma, recently announced a significant push into this category. By partnering with global leaders like Oura, the retailer intends to offer sophisticated monitoring tools to Indian consumers. This expansion signifies a shift from basic tracking to continuous, proactive health management.
Consumer devices are evolving from basic step counters into clinical-grade health companions. Croma is betting on emerging formats like smart rings to provide continuous data on sleep, recovery, and heart rate variability. Furthermore, these devices offer a discreet way for users to manage their wellness proactively. Consequently, the retailer is positioning these products in the premium and mass-premium segments to attract health-conscious buyers. Additionally, this move reflects a broader trend where electronic retailers prioritize health-tech to meet rising demand.
Medical professionals often encounter patients who track their biometrics through these advanced devices. Smart rings utilize photoplethysmography sensors to measure blood flow and physiological changes. Moreover, some studies show that these devices can detect early signs of illness or hormonal shifts. Because users wear rings continuously, the data collected provides a more stable baseline than intermittent clinic visits. Therefore, clinicians might find this longitudinal data useful during consultations. Nevertheless, users must remember that these are not substitutes for professional medical diagnosis.
Q1: How do smart rings differ from traditional fitness trackers?
Smart rings focus on continuous, discreet monitoring of vital signs like heart rate variability and sleep quality, often with higher battery life and 24/7 wearability compared to bulky smartwatches.
Q2: What is the primary goal of the Croma and Oura partnership?
The partnership aims to bring globally recognized health-tech innovations to the Indian market, specifically targeting preventive health management through advanced insights.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Croma enters a partnership with Oura to bring advanced smart rings and health monitoring technology to India, shifting from fitness to clinical-grade insigh...
4 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
